David Spencer

This inventor holds 1 USPTO granted patent. Top assignee: Absci LLC. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Spencer. Retrieved from https://idiyas.com/inventor/david-spencer-ozznf4m1

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: David Spencer: Innovator in Antibody Compositions

Introduction

David Spencer is a notable inventor recognized for his contributions to the field of biotechnology. He has made significant strides in developing innovative solutions that enhance the understanding and application of antibody compositions.

Latest Patents

David Spencer holds a patent for the invention titled "TL1A Associated Antibody Compositions and Methods of Use." This patent represents his commitment to advancing medical science and improving therapeutic options.

Career Highlights

David Spencer is currently employed at Absci LLC, a company dedicated to revolutionizing the way biologics are developed. His work at Absci LLC showcases his expertise and dedication to innovation in the biotechnology sector.

Collaborations

David has collaborated with talented individuals such as Simon Levine-Gottreich and Matthew McPartlon. These partnerships reflect his ability to work effectively within a team to drive forward innovative projects.

Conclusion

David Spencer is a distinguished inventor whose work in antibody compositions has the potential to impact the field of biotechnology significantly. His contributions and collaborations highlight his role as a key player in advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…